August 2024 - Conference Time!
Banu İyisan gave a talk about our recent research on designing versatile hybrid nanoparticles as cancer therapeutics at the American Chemical Society (ACS) Fall 2024 conference, in the 'Biomaterials and Biointerfaces session.
Banu İyisan gave a talk about our recent research on designing versatile hybrid nanoparticles as cancer therapeutics at the American Chemical Society (ACS) Fall 2024 conference, in the 'Biomaterials and Biointerfaces session.